Epidemiology of human papillomavirus genotypes in pregnant Japanese women

Journal of Human Genetics

Volumn 56, Issue 4, 2011, Pages 313-315

  Yamasaki, Kentaro ^a   Miura, Kiyonori ^a   Shimada, Takako ^a   Miura, Shoko ^a   Abe, Shuhei ^a   Murakami, Makoto ^b   Sameshima, Tetsuro ^c   Fujishita, Akira ^d   Kotera, Kouhei ^e   Kinoshita, Akira ^a   Yoshiura, Koh Ichiro ^a   Masuzaki, Hideaki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Sasebo General Hospital   (Japan)

^c JAPANESE RED CROSS NAGASAKI GENBAKU HOSPITAL   (Japan)

^d Nagasaki Saiseikai Hospital   (Japan)

^e Nagasaki Municipal Hospital   (Japan)

Author keywords

epidemiology; genotype; HPV; infection; pregnancy; uterine cervical neoplasia

Indexed keywords

ADULT; ARTICLE; CONDYLOMA ACUMINATUM; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN TISSUE; INFECTION RISK; JAPANESE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREGNANT WOMAN; PREVALENCE; UTERINE CERVIX BIOPSY; WART VIRUS;

ALPHAPAPILLOMAVIRUS; CERVIX UTERI; FEMALE; GENOTYPE; HUMANS; JAPAN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; SPECIES SPECIFICITY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 79955485982     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2011.11     Document Type: Article

References (21)

1. Shimada, T., Miyashita, M., Miura, S., Nakayama, D., Miura, K., Fukuda, M. et al. Genital human papilloma virus infection in mentally-institutionalized virgins. Gynecol. Oncol. 106, 488-489 (2007). (Pubitemid 47302453)
2. Moscicki, A. B., Palefsky, J., Smith, G., Siboshski, S. & Schoolnik, G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet. Gynecol. 82(Part 1), 578-585 (1993). (Pubitemid 23278262)
3. Woodman, C. B., Collins, S., Winter, H., Bailey, A., Ellis, J., Prior, P. et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 357, 1831-1836 (2001). (Pubitemid 32539115)
4. Ho, G. Y., Bierman, R., Beardsley, L., Chang, C. J. & Burk, R. D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338, 423-428 (1998). (Pubitemid 28135669)
5. Sethi, S., Muller, M., Schneider, A., Blettner, M., Smith, E., Turek, L. et al. Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women. Am. J. Obstet. Gynecol. 178, 360-364 (1998). (Pubitemid 28124141)
6. Michelin, D., Gissmann, L., Street, D., Potkul, R. K., Fisher, S., Kaufmann, A. M. et al. Regulation of human papillomavirus type 18 in vivo: effects of estrogen and progesterone in transgenic mice. Gynecol. Oncol. 66, 202-208 (1997). (Pubitemid 27335404)
7. Gravitt, P. E., Peyton, C. L., Alessi, T. Q., Wheeler, C. M., Coutlee, F., Hildesheim, A. et al. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38, 357-361 (2000). (Pubitemid 30043317)
8. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189, 12-19 (1999). (Pubitemid 29406813)
9. Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K. V. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348, 518-527 (2003). (Pubitemid 36159887)
10. Asato, T., Maehama, T., Nagai, Y., Kanazawa, K., Uezato, H. & Kariya, K.-I.Alarge Casecontrol study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J. Infect. Dis. 189, 1829-1832 (2004). (Pubitemid 38657219)
11. Kemp, E. A., Hakenewerth, A. M., Laurent, S. L., Gravitt, P. E. & Stoerker, J. Human papillomavirus prevalence in pregnancy. Obstet. Gynecol. 79, 649-656 (1992).
12. Banura, C., Franceschi, S., van Doorn, L. J., Arslan, A., Kleter, B., Wabwire-Mangen, F. et al. Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala, Uganda. Int. J. Cancer. 123, 2180-2187 (2008).
13. Chan, P. K., Chang, A. R., Tam, W. H., Cheung, J. L. & Cheng, A. F Prevalence and genotype distribution of cervical human papillomavirus infection: comparison between pregnant women and non-pregnant controls. J. Med. Virol. 67, 583-588 (2002). (Pubitemid 34747681)
14. Morrison, E. A., Gammon, M. D., Goldberg, G. L., Vermund, S. H. & Burk, R. D. Pregnancy and cervical infection with human papillomaviruses. Int. J. Gynaecol. Obstet. 54, 125-130 (1996). (Pubitemid 26325290)
15. Takakuwa, K., Mitsui, T., Iwashita, M., Kobayashi, I., Suzuki, A., Oda, T. et al. Studies on the prevalence of human papillomavirus in pregnant women in Japan. J. Perinat. Med. 34, 77-79 (2006). (Pubitemid 43106302)
16. Fife, K. H., Katz, B. P., Brizendine, E. J. & Brown, D. R. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am. J. Obstet. Gynecol. 180, 1110-1114 (1999). (Pubitemid 29259002)
17. Rando, R. F., Lindheim, S., Hasty, L., Sedlacek, T. V., Woodland, M. & Eder, C. Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am. J. Obstet. Gynecol. 161, 50-55 (1989). (Pubitemid 19185743)
18. Nobbenhuis, M. A., Helmerhorst, T. J., van den Brule, A. J., Rozendaal, L., Bezemer, P. D., Voorhorst, F. J. et al. High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. Br. J. Cancer. 87, 75-80 (2002).
19. Miura, S., Matsumoto, K., Oki, A., Satoh, T., Tsunoda, H., Yasugi, T. et al. Do we need a different strategy for HPV screening and vaccination in East Asia? Int. J. Cancer. 119, 2713-2715 (2006). (Pubitemid 44691332)
20. Inoue, M., Sakaguchi, J., Sasagawa, T. & Tango, M. The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population. Int. J. Gynecol. Cancer. 16, 1007-1013 (2006). (Pubitemid 43886718)
21. Paavonen, J., Naud, P., Salmeron, J., Wheeler, C. M., Chow, S. N., Apter, D. et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 374, 301-314 (2009).